Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Recombinant DNA and Genetic Experimentation -

Recombinant DNA and Genetic Experimentation (eBook)

Proceedings of a Conference on Recombinant DNA, Jointly Organised by the Committee on Genetic Experimentation (COGENE) and the Royal Society of London, Held at Wye College, Kent, UK, 1-4 April, 1979
eBook Download: EPUB
2013 | 1. Auflage
334 Seiten
Elsevier Science (Verlag)
978-1-4831-4706-2 (ISBN)
Systemvoraussetzungen
54,39 inkl. MwSt
(CHF 53,10)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Recombinant DNA and Genetic Experimentation contains papers from the Proceedings of a Conference on Recombinant DNA held in London on April 1-4, 1979. This books reviews recombinant DNA research and discusses advances in the application of recombinant DNA research and the regulations affecting such research. Part 1 of the book deals with recombinant DNA techniques that are useful in the biological perspective. These techniques include tests for rare gene exchanger and laboratory genetic manipulations. Part 2 addresses the achievements of recombinant DNA research such as the detection of homologous sequences and progress made in the research of animal viruses. Part 3 discusses the practical benefits of recombinant DNA research, covering topics such as the production of valuable proteins in alternate biological hosts. These proteins are shown as being valuable to society, besides being scientific curiosities. An important presentation is Part 4 of the symposium, which discusses the guidelines and legislations affecting recombinant DNA research such as prior restraint, prohibitions, risks, and approval of the conduct of such experiments. Part 5 concerns a review of the basic assumptions made in the symposium, while Part 6 tackles the question of what options are left open in the international arena, in the medical field, and in the eyes of the public. This collection of papers can prove beneficial for molecular biologists, DNA researchers, molecular geneticists, ecologists and endocrinologists, and pharmacologists.
Recombinant DNA and Genetic Experimentation contains papers from the Proceedings of a Conference on Recombinant DNA held in London on April 1-4, 1979. This books reviews recombinant DNA research and discusses advances in the application of recombinant DNA research and the regulations affecting such research. Part 1 of the book deals with recombinant DNA techniques that are useful in the biological perspective. These techniques include tests for rare gene exchanger and laboratory genetic manipulations. Part 2 addresses the achievements of recombinant DNA research such as the detection of homologous sequences and progress made in the research of animal viruses. Part 3 discusses the practical benefits of recombinant DNA research, covering topics such as the production of valuable proteins in alternate biological hosts. These proteins are shown as being valuable to society, besides being scientific curiosities. An important presentation is Part 4 of the symposium, which discusses the guidelines and legislations affecting recombinant DNA research such as prior restraint, prohibitions, risks, and approval of the conduct of such experiments. Part 5 concerns a review of the basic assumptions made in the symposium, while Part 6 tackles the question of what options are left open in the international arena, in the medical field, and in the eyes of the public. This collection of papers can prove beneficial for molecular biologists, DNA researchers, molecular geneticists, ecologists and endocrinologists, and pharmacologists.

PARTICIPANTS


MARIJA ALACEVIC,     Faculty of Technology, University of Zagreb, Laboratory of Industrial Microbiology, 41000 Zagreb, Yugoslavia

I. ALTOSAAR,     Biochemistry Department, University of Ottawa, Ottawa, Ontario, Canada

L.J. ARCHER,     Molecular Genetics Group, Gulbenkian Institute of Science, Oeiras, Portugal

K. AUNSTRUP,     NOVO Research Institute, NOVO ALLE, DK-2880, Bagsvaerd, Denmark

A.A. BAYEV, (COGENE),     Institute of Molecular Biology, Academy of Sciences, 32 Vavilov Street, Moscow 117312, USSR

G. BERNARDI, (COGENE), I.R.B.M., CNRS,     Universite Paris VII - Tour 43, 2 Place Jussieu, 75221 Paris Cedex 05, France

G. BERTANI,     Institute of Microbial Genetics, Karolinska Institutet, S-104 01 Stockholm, Sweden

J.H. BIRKNER,     5008 Alta Loma Road, Colorado Springs, Colorado 80918, USA

J. BIRNBAUM,     Merck Institute for Therapeutic Research, PO Box 2000, Rahway, New Jersey 07065, USA

F. BLASI,     Centro di Endocrinologia e Oncologia, Sperimentale del CNR, Via S. Pansini 5, 80131 Naples, Italy

W.F. BODMER,     Genetics Laboratory, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, UK

R. BREATHNACH,     Laboratoire de Genetique Moleculaire des Eukaryotes du CNRS, Faculte de Medecine, 11 Rue Humann, 67085 Strasbourg Cedex, France

F. BROWN,     Animal Virus Research Institute, Pirbright, Woking, Surrey, UK

A. CAMPBELL,     Department of Biological Sciences, Stanford University, Stanford, California 94305, USA

R. CAPE,     Cetus Corporation, 600 Bancroft Way, Berkeley, California 94710, USA

A.R. CASHMORE,     Royal Society of New Zealand, c/o Applied Biochemistry Division, DSIR Private Bag, Palmerston North, New Zealand

S. CHANG,     Cetus Corporation, Recombinant Molecular Research, 600 Bancroft Way, Berkeley, California 94710, USA

T-Y CHOW,     Institute of Botany, Academia Sinica, Taipei, Taiwan 115

PATRICIA CLARKE,     Department of Biochemistry, University College London, Gower Street, London WC1E 6BT, UK

S.N. COHEN, (COGENE),     Department of Genetics, Stanford University, Room S-337, Stanford, California 94305, USA

J.D. COOMBES,     Hoechst Pharmaceutical Research Laboratories, Walton Manor, Milton Keynes, Bucks. MK17 9PJ, UK

P.E. CORNELIS,     Universite Catholique de Louvain, Laboratoire de Cytogenetique, Institute Carnoy, 4 Place Croix du Sud, 1348 Louvain-la-Neuve, Belgium

R.A. COX,     National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK

R.K. CRAIG,     Courtauld Institute of Biochemistry, Middlesex Hospital Medical School, Mortimer Street, London W1P 7PN, UK

J. DAVISON,     Unit of Molecular Biology, International Institute of Cellular and Molecular Pathology, Avenue Hippocrate 75, B-1200 Brussels, Belgium

V. DEBABOV,     Institute of Genetics & Selection of Industrial Microorganisms, Dorozhnaya 8, Moscow 113545, USSR

S.D. EHRLICH,     Institut de Recherche en Biologie Moleculaire, Universite Paris VII, 2 Place Jussieu, 75221 Paris, France

I. FEDORCSAK, (COGENE),     Division of Scientific Research and Higher Education, UNESCO House, 7 Place de Fontenoy, 75700 Paris, France

W. FIERS,     Laboratory of Molecular Biology, Ledeganekstraat 35, B-9000 Ghent, Belgium

MAGDALENA FIKUS,     Institute of Biochemistry & Biophysics, Polish Academy of Sciences, Rakowiecka 36, 02–532 Warsaw, Poland

J.R.S. FINCHAM,     Department of Genetics, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, Scotland, UK

S.W. FISHER,     Imperial Cancer Research Fund, 44 Lincoln’s Inn Fields, London WC2A 3PX, UK

R.B. FLAVELL,     Plant Breeding Institute, Trumpington, Cambridge CB2 2LQ, UK

I.I. FODOR,     Institute of Biochemistry & Physiology of Microorganisms, Pushchino 142292, Moscow, USSR

M. FRIED,     Imperial Cancer Research Fund Laboratories, PO Box 123, Lincoln’s Inn Fields, London WC2A 3PX, UK

A. FURUYA,     Tokyo Research Laboratory, Kyowa Hakko Kogyo Co. Limited, 3-6-6 Asahicho, Machidashi, Tokyo 194, Japan

W.J. GARTLAND,     Director, Office of Recombinant DNA Activities, NIGMS, Building 31, Room 4A52, Bethesda, Maryland 20014, USA

T. GEFFEN,     Department of Health, Alexander Fleming House, Elephant and Castle, London SE1 6BY, UK

E. GEISSLER,     Akademie der Wissenschaften der DDR, Zentralinstitut fur Molekularbiologie, Lindenberger Weg 70, DDR-1115, Berlin-Buch, DDR

MARY-JANE GETHING,     Imperial Cancer Research Fund, PO Box 123, Lincoln’s Inn Fields, London WC2A 3PX, UK

K.I. GIBSON,     Department of Education and Science, Medical Research Council, 20 Park Crescent, London W.1., UK

JACQUELINE GITS,     Smith Kline-Rit S.A., 89 Rue de l’Institut, B-1330 Rixensart, Belgium

W. GOEBEL,     Institut fur Genetik und Mikrobiologie, Rontgenring 11, 87 Wurzburg, FRG

DONNA HARBER,     Association of Scientific Technical and Managerial Staffs, 10–26A Jamestown Road, London NW1 7DT, UK

D.O. HAINES,     Health & Safety Executive, 25 Chapel Street, London NW1 5DT, UK

T.J.R. HARRIS,     Animal Virus Research Institute, Pirbright, Woking, Surrey, U.K.

M. HASHMI,     United Nations Environment Programme, PO Box 30552, Nairobi, Kenya, East Africa

L. HATCH,     National Institute for Occupational Safety and Health, 4676 Columbia Parkway (C-17), Cincinnati, Ohio 45226, USA

G. HOLT,     Commission of the European Communities, 14 Adams Square, Crook Log, Bexleyheath, Kent DA6 8BX, UK

T. IINO,     Laboratory of Genetics, Faculty of Science, University of Tokyo, Hongo, Tokyo, Japan

J. INGLE,     Agricultural Research Council, 160 Great Portland Street, London W1N 6DT,...

Erscheint lt. Verlag 22.10.2013
Sprache englisch
Themenwelt Medizin / Pharmazie
Naturwissenschaften Biologie Evolution
ISBN-10 1-4831-4706-1 / 1483147061
ISBN-13 978-1-4831-4706-2 / 9781483147062
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Traits, Interactions, and Applications

von Michal Segoli; Eric Wajnberg

eBook Download (2024)
Wiley (Verlag)
CHF 84,95